Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S40. https://doi.org/10.25251/skin.2.supp.40